Democritus University of Thrace (DUTH)
Χρήση βλαστοκυττάρων στην ανάπτυξη εμβιομηχανικών μοντέλων για την μελέτη φαρμακευτικών παραγόντων στην θεραπεία της εντερικής φλεγμονής
Abstract
dc:descriptionIntroductionRegenerative Medicine is an ever-evolving scientific field that exploits a variety of pluripotent stem cells in different applications. Embryonic Stem Cells (ESCs) are believed to be the most suitable candidates for the majority of these applications, as they possess great self-renewal capabilities and differentiation potential; nevertheless, there are also significant limitations in their exploitation, such as their inadequate availability and strong ethical dilemmas that rise regarding their isolation and use. An important application of ESCs is their implementation in the development of organoids, 3D biological structures that resemble different organs, for example gut, heart, or lung. Human Intestinal Organoids (HIOs), which are derived from pluripotent stem cells via a multi-stage procedure that simulates organogenesis, are considered a promising new in vitro model for various applications. Their structure and cellular composition resemble that of the intestinal mucosa, as they consist of both mesenchymal and all the intestinal epithelial cells, forming 3D structures that incorporate crypts and villi. Their complex cellular composition and human origin makes them preferable experimental models over the classic cell cultures and animal models, respectively, and therefore HIOs are considered a valuable tool for intestinal inflammation and fibrosis studies. However, due to their complexity, several factors associated with their use in in vitro studies, have not been adequately investigated.Identifying alternative sources of pluripotent stem cells is a major priority of regenerative medicine. The discovery of the very small embryonic-like stem cells (VSELs), which express embryonic pluripotent markers and can also be found in adult tissues, attempted to address the aforementioned limitations of ESCs. However, their isolation technique has been a challenge for many research teams due to the small size of these cells and their seemingly low isolated number, leading to their limited exploitation. VSELs could be used in a variety of Bioengineering applications, such as the development of complex three-dimensional intestinal structures to study intestinal inflammation and fibrosis.AimThe aim of this doctoral thesis was the generation of intestinal organoids from human stem cells and their application on studying pharmaceutical substances for the treatment of intestinal inflammation and fibrosis, as well as the development of basic structures for possible use as artificial grafts/tissues.Specifically, in the first part of the present doctoral thesis, the aim was the development of Human Intestinal Organoids (HIOs) from the H1 embryonic stem cell line and the identification of their different developmental stages. An additional aim was the study of the expression of fibrotic and mesenchymal markers during HIOs maturation process and the investigation of the effect of pro-inflammatory cytokines, IL-1α and TNF-α, on the expression of fibrotic and inflammatory mediators in HIOs, at different culture stages.In the second part, the aim was to isolate stem cells from peripheral blood, identify them with various markers of embryonic, hematopoietic, and mesenchymal stem cells, as well as study their pluripotency.Materials and MethodsIn the first part of this doctoral thesis, the H1 embryonic stem cell line was cultured and then differentiated into HIOs, using a commercially available kit. All the developmental stages of HIOs were characterized by immunofluorescence. In order to examine their evolution, we compared the mRNA expression of fibrotic and mesenchymal markers in passages 1-10. In order to test their functionality, HIOs from different passages were stimulated with 5ng/ml IL-1α and 50ng/ml TNF-α for 12 or 48 hours; at the end of the 12-hour incubation, total RNA was collected and the fibrotic mRNA expression of fibronectin, collagen type I and type III, Tissue Factor (TF) and α-SMA, the inflammatory mRNA expression of CXCL1, CXCL8, CXCL10, CXCL11, CCL2 and CCL20, and the mRNA expression of tight junction proteins OCLN, CLDN1, ZO1 and JAMA were examined with reverse transcription quantitative PCR. At the end of the 48-hour incubation, the culture supernatants were collected and the inflammatory protein expression of CXCL1, CXCL8, CXCL10, CXCL11, CCL2 and CCL20 was examined by ELISA.In the second part, small pluripotent stem cells were isolated from peripheral blood, which were first counted and then characterized with markers of embryonic, mesenchymal, or hematopoietic stem cell origin using immunofluorescence. In addition, small pluripotent stem cells were differentiated into cells of the mesodermal lineage, and in particular into adipocytes, osteocytes, and chondrocytes, using commercially available reagents. ResultsIn the first part of this doctoral thesis, the embryonic stem cell line H1 was cultured and expanded in order to create a ESCs biobank. Subsequently, we successfully developed ESCs-derived organoids by using specific growth factors. Through characterization assays, these organoids proved to be HIOs that consist of both mesenchymal and epithelial component. The evaluation of the expression of mesenchymal and extracellular matrix (ECM) markers, showed that HIOs have a sufficiently developed mesenchymal component, which is gradually reduced through culture passages, while their epithelial component remained intact. In particular, there was high mRNA expression of CD90, collagen type I, III and fibronectin in the early passages, but this expression was gradually decreased in the later passages. The pro-inflammatory cytokines IL-1α and TNF-α induced the mRNA expression of fibronectin, collagen type I, III, TF and α-SMA mainly in early passages. Similarly, strong chemokine responses (CXCL10, CXCL1, CCL2, CXCL8 and CCL20) were observed at the mRNA and protein level in early but not later passages. In contrast, the tight junction proteins, CLDN1 and JAMA, responded to inflammatory stimulation regardless of the HIOs’ passage. These studies verified the functionality of HIOs and suggested that HIOs are a useful tool for the study of intestinal inflammation and fibrosis. In the second part, SBSCs were successfully isolated by using a pure mechanical process, which yielded higher results compared to the current bibliography. SBSCs were found to express various embryonic markers, such as Nanog, SSEA-3 and the Yamanaka factors (SOX-2, Oct-4, cMyc and KLF4). In addition, a fraction of them expressed hematopoietic markers, such as CD45 and CD90, and/or mesenchymal markers, such as CD29, CD105, and PTH1R, suggesting that SBSCs are a mixed pluripotent cell population. The pilot functional tests that followed showed that the SBSCs could be differentiated into the mesodermal lineage, resulting in the formation of adipocytes, osteocytes, and chondrocytes.ConclusionsIn conclusion, the current doctoral thesis presented the successful development of HIOs from embryonic stem cells. HIOs contained a functional epithelial and mesenchymal component, with the latter being active mainly during the early passages, indicating that HIOs are a novel tool for the study of intestinal inflammation and fibrosis. Therefore, this model is proposed for the study of epithelial-mesenchymal interactions in early HIOs passages when the mesenchymal component is active. Finally, the current doctoral thesis presented a new and easy process of isolating small stem cells from peripheral blood, yielding an abundant population with pluripotent characteristics, which has the potential to be differentiated to other cell types and could provide an important stem cell source for the development of autologous organoids.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kandilogiannakis, Leonidas
- Κανδηλογιαννάκης, Λεωνίδας
Subjects
dc:subject × 23- Εμβιομηχανική
- Αναγεννητική ιατρική
- Εντερικά οργανίδια
- Φλεγμονή
- Ανθρώπεια Εμβρυικά Βλαστοκύτταρα
- Ίνωση
- Bioengineering
- Regenerative medicine
- Intestinal organoids
- Inflammation
- Human embryonic stem cells
- Fibrosis
- Ιατρική Βιοτεχνολογία
- Ιατρική και Επιστήμες Υγείας
- Βιοϊατρική Μηχανική
- Επιστήμες Μηχανικού και Τεχνολογία
- Μηχανική κυττάρων και ιστών
- Medical Biotechnology
- Medical and Health Sciences
- Medical Engineering
- Engineering and Technology
- Cell and Tissue Engineering
- Biomedical Engineering
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51739